VOYA Investment Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-12,998
| Closed | -$107K | – | 2609 |
|
|
2025
Q2 | $107K | Hold |
12,998
| – | – | ﹤0.01% | 2479 |
|
|
2025
Q1 | $92.9K | Sell |
12,998
-30,504
| -70% | -$227K | ﹤0.01% | 2449 |
|
|
2024
Q4 | $336K | Buy |
43,502
+3,024
| +7% | +$28.4K | ﹤0.01% | 2143 |
|
|
2024
Q3 | $425K | Buy |
40,478
+1,075
| +3% | +$13.1K | ﹤0.01% | 2089 |
|
|
2024
Q2 | $461K | Sell |
39,403
-21,937
| -36% | -$341K | ﹤0.01% | 2051 |
|
|
2024
Q1 | $1.29M | Buy |
61,340
+15,751
| +35% | +$280K | ﹤0.01% | 1521 |
|
|
2023
Q4 | $818K | Sell |
45,589
-58
| -0.1% | -$1.02K | ﹤0.01% | 1793 |
|
|
2023
Q3 | $751K | Buy |
45,647
+2,952
| +7% | +$53.5K | ﹤0.01% | 1816 |
|
|
2023
Q2 | $853K | Buy |
42,695
+4,775
| +13% | +$92K | ﹤0.01% | 1763 |
|
|
2023
Q1 | $717K | Buy |
37,920
+1,019
| +3% | +$22.5K | ﹤0.01% | 1838 |
|
|
2022
Q4 | $837K | Buy |
36,901
+9,454
| +34% | +$214K | ﹤0.01% | 1739 |
|
|
2022
Q3 | $725K | Buy |
27,447
+2,842
| +12% | +$84.3K | ﹤0.01% | 1801 |
|
|
2022
Q2 | $608K | Sell |
24,605
-1,385
| -5% | -$34.6K | ﹤0.01% | 1712 |
|
|
2022
Q1 | $863K | Hold |
25,990
| – | – | ﹤0.01% | 1564 |
|
|
2021
Q4 | $850K | Sell |
25,990
-196
| -0.7% | -$6.67K | ﹤0.01% | 1656 |
|
|
2021
Q3 | $1.1M | Buy |
26,186
+314
| +1% | +$11.3K | ﹤0.01% | 1498 |
|
|
2021
Q2 | $1M | Sell |
25,872
-190
| -0.7% | -$6.79K | ﹤0.01% | 1626 |
|
|
2021
Q1 | $889K | Buy |
26,062
+806
| +3% | +$34.4K | ﹤0.01% | 1672 |
|
|
2020
Q4 | $1.15M | Buy |
25,256
+2,953
| +13% | +$103K | ﹤0.01% | 1431 |
|
|
2020
Q3 | $614K | Buy |
22,303
+422
| +2% | +$13.8K | ﹤0.01% | 1546 |
|
|
2020
Q2 | $806K | Sell |
21,881
-4,912
| -18% | -$183K | ﹤0.01% | 1377 |
|
|
2020
Q1 | $868K | Sell |
26,793
-110,116
| -80% | -$4.59M | ﹤0.01% | 1300 |
|
|
2019
Q4 | $5.61M | Sell |
136,909
-126,684
| -48% | -$5M | 0.01% | 770 |
|
|
2019
Q3 | $9.38M | Buy |
263,593
+48,368
| +22% | +$1.96M | 0.02% | 615 |
|
|
2019
Q2 | $11.1M | Sell |
215,225
-17,041
| -7% | -$851K | 0.02% | 577 |
|
|
2019
Q1 | $13.3M | Sell |
232,266
-27,937
| -11% | -$1.38M | 0.03% | 487 |
|
|
2018
Q4 | $10.9M | Sell |
260,203
-12,838
| -5% | -$753K | 0.03% | 514 |
|
|
2018
Q3 | $20.6M | Buy |
273,041
+69,484
| +34% | +$5.01M | 0.04% | 424 |
|
|
2018
Q2 | $14.6M | Buy |
203,557
+190,949
| +1,515% | +$9.12M | 0.03% | 516 |
|
|
2018
Q1 | $376K | Hold |
12,608
| – | – | ﹤0.01% | 1977 |
|
|
2017
Q4 | $419K | Hold |
12,608
| – | – | ﹤0.01% | 1955 |
|
|
2017
Q3 | $415K | Hold |
12,608
| – | – | ﹤0.01% | 1983 |
|
|
2017
Q2 | $249K | Buy |
+12,608
| New | +$244K | ﹤0.01% | 2280 |
|
Other funds holding RGNX
RG
VOYA Investment Management's RGNX Position: Q3 2025 in Review
VOYA Investment Management sold out of Regenxbio (RGNX) in Q3 2025, closing a stake of 12,998 shares — an estimated $107K sold.
VOYA Investment Management first reported a position in RGNX in Q2 2017 and held it in 33 quarters. The position peaked at $20.6M in Q3 2018. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2025.
- VOYA Investment Management reported no remaining Regenxbio position as of Q3 2025 after selling out during the quarter.
- VOYA Investment Management sold 12,998 Regenxbio shares in Q3 2025, an estimated $107K.
- VOYA Investment Management first reported a position in Regenxbio in Q2 2017 and held it in 33 quarters.
- VOYA Investment Management's Regenxbio position peaked at $20.6M in Q3 2018.
- 166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2025.
Based on VOYA Investment Management's 13F filing for Q3 2025, filed 9 Oct 2025.